FindTrial
Sign In

A clinical trial to study the effects of atorvastatin in patients with chronic obstructive pulmonary disease.

An open label clinical trial to study the effect of atorvastatin on COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/11/003162
Enrollment
60
Registered
2012-11-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic obstructive pulmonary disease

Interventions

Intervention1: Atorvastatin: 20 mg OD for 3 months Intervention2: atovastatin: 20mg Control Intervention1: no intervention: no intervention

Sponsors

Dr Manisha Bisht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with COPD in stable condition for more than 3months 2. Patient having abnormal lipid profile (LDL-130-160 mg/dl)

Exclusion criteria

Exclusion criteria: 1. Patients with bronchial asthma 2. Patients with prior exposure to statins. 3. Patients with acute exacerbation of COPD for less than 3months 4. Patients with any active infection, renal disease for less than 3months 5. Patients with history of liver dysfunction 6. Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
pulmonary function test, lipid profile, Hs CRP health related quality of life questionnaire (SGRQ)Timepoint: 3 months—

Secondary

MeasureTime frame
and health related quality of life questionnaire (SGRQ)Timepoint: 3 month—

Countries

India

Contacts

Public ContactDr Manisha Bisht

Himalayan institute of medical sciences, HIHT university

manishabisht@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026